4fdi: Difference between revisions
No edit summary |
No edit summary Tag: Manual revert |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==The molecular basis of mucopolysaccharidosis IV A== | ==The molecular basis of mucopolysaccharidosis IV A== | ||
<StructureSection load='4fdi' size='340' side='right' caption='[[4fdi]], [[Resolution|resolution]] 2.20Å' scene=''> | <StructureSection load='4fdi' size='340' side='right'caption='[[4fdi]], [[Resolution|resolution]] 2.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4fdi]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4fdi]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FDI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4FDI FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=DDZ:3,3-DIHYDROXY+L-ALANINE'>DDZ</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4fdi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4fdi OCA], [https://pdbe.org/4fdi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4fdi RCSB], [https://www.ebi.ac.uk/pdbsum/4fdi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4fdi ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Disease == | == Disease == | ||
[ | [https://www.uniprot.org/uniprot/GALNS_HUMAN GALNS_HUMAN] Mucopolysaccharidosis type 4A. The disease is caused by mutations affecting the gene represented in this entry. | ||
== Function == | |||
[https://www.uniprot.org/uniprot/GALNS_HUMAN GALNS_HUMAN] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 24: | Line 23: | ||
==See Also== | ==See Also== | ||
*[[Sulfatase 3D structures|Sulfatase 3D structures]] | |||
*[[Sulfatase|Sulfatase]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Garman | [[Category: Garman SC]] | ||
[[Category: Rivera-Colon | [[Category: Rivera-Colon Y]] | ||
Latest revision as of 13:50, 6 November 2024
The molecular basis of mucopolysaccharidosis IV AThe molecular basis of mucopolysaccharidosis IV A
Structural highlights
DiseaseGALNS_HUMAN Mucopolysaccharidosis type 4A. The disease is caused by mutations affecting the gene represented in this entry. FunctionPublication Abstract from PubMedLysosomal enzymes catalyze the breakdown of macromolecules in the cell. In humans, loss of activity of a lysosomal enzyme leads to an inherited metabolic defect known as a lysosomal storage disorder. The human lysosomal enzyme galactosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6.4) is deficient in patients with the lysosomal storage disease mucopolysaccharidosis IV A (also known as MPS IV A and Morquio A). Here, we report the three-dimensional structure of human GALNS, determined by X-ray crystallography at 2.2A resolution. The structure reveals a catalytic gem diol nucleophile derived from modification of a cysteine side chain. The active site of GALNS is a large, positively charged trench suitable for binding polyanionic substrates such as keratan sulfate and chondroitin-6-sulfate. Enzymatic assays on the insect-cell-expressed human GALNS indicate activity against synthetic substrates and inhibition by both substrate and product. Mapping 120 MPS IV A missense mutations onto the structure reveals that a majority of mutations affect the hydrophobic core of the structure, indicating that most MPS IV A cases result from misfolding of GALNS. Comparison of the structure of GALNS to paralogous sulfatases shows a wide variety of active-site geometries in the family but strict conservation of the catalytic machinery. Overall, the structure and the known mutations establish the molecular basis for MPS IV A and for the larger MPS family of diseases. The Structure of Human GALNS Reveals the Molecular Basis for Mucopolysaccharidosis IV A.,Rivera-Colon Y, Schutsky EK, Kita AZ, Garman SC J Mol Biol. 2012 Aug 29. PMID:22940367[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||